Detailed genomic, transcriptomic, and epigenomic analyses were performed to elucidate the molecular mechanisms of FOXR2 activation in specific CNS tumor types and the downstream effects of FOXR2 activation. Here, FOXR2 is linked to central nervous system neoplasm.